October is Breast Cancer Awareness Month in the U.S., meaning now is the time to learn more about the disease, the genetic component to a common breast cancer medication and steps women can take to detect the disease early. Breast cancer strikes about one in eight women in the U.S. and is the second leading cause of cancer death in … Read More
Flawed studies informed recommendations against CYP2D6 testing for tamoxifen treatment, new study finds
A recent Mayo Clinic study has found that clinical recommendations discouraging the use of CYP2D6 genetic testing to advise tamoxifen treatment in women with breast cancer should be reconsidered because some of the studies the recommendations were based on had flawed methodology. The article, published in the January issue of the Journal of the National Cancer Institute, found that some … Read More